Reported:
Partial List of Issued US Patents: USSN 7,579,366 ("Epothilone derivatives and their synthesis and use"); USSN 7,410,998 ("Inhibitors of NADH:ubiquinone oxidoreductase"); USSN 7,408,026 ("Synthesis of proteins by native chemical ligation"); USSN 7,375,234 ("Copper-catalysed ligation of azides and acetylenes"); USSN 7,358,266 ("Cyclopropyl and cyclobutyl epothilone analogs"); USSN 7,351,724 ("Oxadiazole ketone inhibitors of fatty acid amide hydrolase"); USSN 7,348,173 ("Fatty-acid amide hydrolase"); USSN 7,312,361 ("Inhibitors of transthyretin amyloid fibril formation"); USSN 7,288,623 ("Cyclic peptide tube"); USSN 7,250,409 ("Ningalin B analogs employable for reversing multidrug resistance"); USSN 7,173,137 ("Epothilone analogs"); USSN 7,169,930 ("Analogs of epothilone"); USSN 7,135,578 ("Iminocyclitol inhibitors of hexoaminidase and glycosidase"); USSN 7,135,279 ("D-enzyme compositions and methods of their use"); USSN 7,126,006 ("Glycoluril core molecules for combinatorial libraries"); USSN 7,118,856 ("D-enzyme compositions and methods of their use"); USSN 7,019,131 ("Programmable one-pot oligosaccharide synthesis"); USSN 7,015,321 ("Synthesis of non-symmetrical sulfamides using burgess-type reagents"); USSN 6,921,810 ("Bifunctional antibiotics"); USSN 6,900,238 ("HIV protease inhibitors"); USSN 6,891,043 ("Inhibitors of fatty acid amide hydrolase"); USSN 6,858,649 ("Selective potentiation of serotonin receptor subtypes"); USSN 6,852,874 ("Second cycle asymmetric dihydroxylation reaction"); USSN 6,849,398 ("Use of encoded reaction cassette"); USSN 6,803,466 ("HIV/FIV protease inhibitors having a small P3 residue"); USSN 6,774,140 ("Iminocyclitol inhibitors of hexoaminidase and glycosidase"); USSN 6,734,204 ("Serotonin potentiation by oleamide analogs"); USSN 6,664,372 ("Azatide peptidomimetics"); USSN 6,660,758 ("Epothilone analogs"); USSN 6,653,087 ("Convergent synthesis of combinatorial library"); USSN 6,642,357 ("Process for preparing modified proteins"); USSN 6,642,035 ("Synthesis of B-keto esters"); USSN 6,613,875 ("Cyclic peptide tube"); USSN 6,573,387 ("Synthesis of .alpha.,.beta.-substituted amino amides, esters, and acids"); USSN 6,548,530 ("CBI analogs of CC-1065 and the duocarmycins"); USSN 6,548,279 ("D-enzyme compositions and methods of their use"); USSN 6,538,117 ("Programmable one-pot oligosaccharide synthesis"); USSN 6,531,497 ("Epothilone derivatives and their synthesis and use"); USSN 6,518,418 ("Nucleotide sugars"); USSN 6,509,506 ("Two step synthesis of D- and L- .alpha.-amino acids and D- and L- .alpha.-amino aldehydes"); USSN 6,495,314 ("Process for characterizing proteins"); USSN 6,486,326 ("Iso-CBI and iso-CI analogs of CC-1065 duocarmycins"); USSN 6,476,190 ("Process for preparing modified proteins"); USSN 6,462,193 ("Hydroxyazepanes as inhibitors of glycosidase and HIV protease"); USSN 6,462,054 ("Inhibitors of fatty acid amide hydrolase"); USSN 6,441,186 ("Epothilone analogs"); USSN 6,423,834 ("KDO aldolase and condensation reactions employed therewith"); USSN 6,380,394 ("Epothilone analogs"); USSN 6,368,839 ("Aldolase catalytic antibody"); USSN 6,350,905 ("Aminohydroxylation of Olefins"); USSN 6,329,497 ("Sandramycin analogs"); USSN 6,310,209 ("Synthesis of CC-1065/duocarmycin analogs"); USSN 6,307,018 ("General chemical ligation"); USSN 6,294,374 ("Use of catalytic antibodies for synthesizing epothilone"); USSN 6,271,400 ("Epoxidation of olefins"); USSN 6,271,384 ("Self-assembled taxo-diterpenoid nanostructures"); USSN 6,262,271 ISO-CBI and ISO-CI analogs of CC-1065 and the duocarmycins"); USSN 6,255,088 ("Enzymatic sulfation of biomolecules"); USSN 6,252,094 ("Chemical switching of taxo-diterpenoids between low solubility active forms and high solubility inactive forms"); USSN 6,232,450 ("Inhibition of human fucosyltransferases with N-linked Lewis-x and LacNAc analogs"); USSN 6,210,938 ("Antibody catalysis of enantio- and diastereo-selective aldol reactions"); USSN 6,204,376 ("Carbopeptoids and carbonucleotoids"); USSN 6,184,344 ("Synthesis of proteins by native chemical ligation"); USSN 6,140,041 ("Fluorescent dye"); USSN 6,120,997 ("Nucleic acid binders having an hydroxyamine motif"); USSN 6,111,084 ("Fuopeptide mimetics"); USSN 6,096,784 ("Inhibitors of oleamide hydrolase"); USSN 6,080,563 ("Method for synthesizing 2-ketoaldonic acids"); USSN 6,060,608 ("Analogs of CC-1065 and the duocarmycins"); USSN 6,057,473 ("Synthesis of aryl serines"); USSN 6,043,382 ("Transformations of taxol"); USSN 6,040,133 ("D-enzyme compositions and methods of their use"); USSN 6,025,491 ("Water soluble onium salt of taxo-diterpenoid"); USSN 6,008,376 ("Aminohydroxylation of olefins with tert-alkyl sulfonamides"); USSN 5,994,583 ("Two step synthesis of D- and L- .alpha.-amino acids and D- and L- .alpha.-amino-aldehydes"); USSN 5,985,908 ("MCBI analogs of CC-1065 and the duocarmycins"); USSN 5,985,626 ("Catalytic antibody/substrate intermediates"); USSN 5,981,267 ("Enantioselection of amines using homocarbonates with hydrolase"); USSN 5,965,718 ("Analogs of sarcodictyin and eleutherobin"); USSN 5,962,660 ("Sialyl Lewis X mimetics incorporating fucopeptides"); USSN 5,958,673 ("Fluorescent dye"); USSN 5,939,568 ("Accelerated catalysis of olefinic epoxidations"); USSN 5,929,252 ("Aziridination of olefins"); USSN 5,910,437 ("D-enzyme compositions and methods of their use"); USSN 5,891,993 ("Template assembled synthetic protein"); USSN 5,876,981 ("Transglycosylation reactions employing .beta.-galactosidase"); USSN 5,869,316 ("Biologically pure culture of aureobacterium barkeri KDO-37-2"); USSN 5,859,281 ("Catalytic asymmetric aminohydroxylation of olefins with sulfonamides"); USSN 5,856,537 ("Inhibitors of oleamide hydrolase"); USSN 5,854,391 ("Glycosylation of peptides using glycosyl phosphite reagents"); USSN 5,854,389 ("Process for preparing modified proteins"); USSN 5,837,862 ("Sialyl Lewis X mimetics incorporating mannopeptides"); USSN 5,830,871 ("Inhibitors of E-, P- and L-selectin binding"); USSN 5,827,827 ("HIV-1 protease inhibitors"); USSN 5,817,840 ("Water soluble taxol derivatives"); USSN 5,807,979 ("Synthetic, three-dimensionally stabilized polypeptide mimics of HIV"); USSN 5,786,489 ("Transformations of taxol"); USSN 5,770,407 ("Process for preparing nucleotide inhibitors of glycosyltransferases"); USSN 5,767,304 ("Catalytic asymmetric aminohydroxylation of olefins with carbamates"); USSN 5,766,887 ("Synthesis of 9-0-acetyl N-acetylneuraminic acid oligosaccharides"); USSN 5,760,240 ("Taxoid synthesis"); USSN 5,759,825 ("Method for synthesizing 2-ketoaldonic acids"); USSN 5,750,691 ("Access to taxol analogs"); USSN 5,733,757 ("Aldolase catalytic antibody"); USSN 5,731,334 ("Method for treating cancer using taxoid onium salt prodrugs"); USSN 5,723,598 ("Encoded combinatorial chemical libraries"); USSN 5,614,615 ("Sialyl Lewis X mimetics incorporating fucopeptides"); USSN 5,612,380 ("Method for sleep induction"); USSN 5,608,087 ("Water soluble taxol derivatives"); USSN 5,599,915 ("Sialyl Lewis X mimetics"); USSN 5,597,906 ("Carbon linked glycosyl compounds"); USSN 5,585,261 ("KDO aldolase"); USSN 5,576,174 ("Catalytic antibody with primary amine cofactor"); USSN 5,573,905 ("Encoded combinatorial chemical libraries"); USSN 5,571,681 ("Chemical event selection by suicide substrate conjugates"); USSN 5,563,121 ("Peptide linkage unit"); USSN 5,559,000 ("Encoded reaction cassette"); USSN 5,550,246 ("Calicheamicin mimics"); USSN 5,506,214 ("Use of substituted adenine derivatives for treating multiple sclerosis"); USSN 5,504,222 ("Transformations of taxol"); USSN 5,504,206 ("Formation of esperamicin precursors"); USSN 5,500,432 ("Induction and inhibition of apoptosis"); USSN 5,500,358 ("Antibody catalysis of cyclohexadienone rearrangments"); USSN 5,481,007 ("Taxoid synthesis"); USSN 5,461,169 ("Total synthesis of taxol and taxol analogs"); USSN 5,440,057 ("Access to taxol analogs"); USSN D360,034 ("Vacuum chamber for housing a blood bag"); USSN 5,422,364 ("Water soluble taxol derivatives"); USSN 5,358,859 ("KDO Aldolase and condensation reactions employed therewith"); USSN 5,282,982 ("Blood washing method"); USSN 5,267,753 ("Holographic bank draft"); USSN D333,870 ("Vacuum chamber for housing a blood bag"); USSN 5,185,269 ("Immunobead aspirator and method of use"); USSN 5,178,602 ("Automatic decanting centrifuge"); USSN 5,160,333 ("Method for mixing blood with anticoagulant"); USSN 5,137,166 ("Seamless overpack and spin welding apparatus for making same"); USSN 5,113,886 ("Apparatus for washing magnetic particles in a vessel with a bottom pull"); USSN 5,105,842 ("Apparatus for washing magnetic particles in a vessel with a bottom pull"); USSN 5,096,093 ("Hand held hydraulic dispenser"); USSN 5,093,104 ("Method for labelling leucocytes with indium in-111 oxine"); USSN 5,085,345 ("Hydraulic dispenser"); USSN 5,047,004 ("Automatic decanting centrifuge"); USSN 5,002,077 ("Periodontal pocket cleaner"); USSN 4,967,606 ("Method and apparatus for pipetting liquids"); USSN 4,825,447 ("Liposomal thermograph and methods for making and using same"); USSN 4,789,631 ("Immunoassay for anti-dirofilaria immitis antibody"); USSN 4,784,709 ("Seamless overpack and spin welding apparatus for making same"); USSN 4,709,695 ("Protective device"); USSN 4,703,001 ("Immunoassay for the detection of serum analytes using pH dependent chastropic acids"); USSN 4,673,501 ("Bottle top filter"); USSN 4,527,437 ("Pipette controller"); USSN 4,467,503 ("Enlaceable serviette"); USSN 4,443,345 ("Serum preparator").